Affiliation:
1. Genitourinary Oncology Program, Baylor Sammons Cancer Center, Dallas, Texas
2. Division of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California
Funder
Genentech, Novartis Pharmaceuticals, Pfizer, Inc., and Wyeth Pharmaceuticals
Amgen, GlaxoSmithKline, Pfizer, and Wyeth
Bayer/Onyx, GlaxoSmithKline, Novartis, Pfizer, and Wyeth
Reference29 articles.
1. Chemotherapy for advanced renal cell carcinoma: 1983‐1993;Yagoda A;Semin Oncol.,1995
2. Principles and Practice of Genitourinary Oncology 1997 Lippincott‐Raven Philadelphia PA RJ Motzer NJ Vogelzang D Raghaven HI Scher SA Leibel Chemotherapy for renal cell carcinoma 885 896
3. A New Method of Estimating United States and State-level Cancer Incidence Counts for the Current Calendar Year
4. Cancer Statistics, 2007
5. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献